Abstract:Locally advanced NSCLC accounts for more than one third of lung cancers at the initial diagnosis. In recent years,some multi-center randomized studies and meta-analysis show that the multi -modality therapy that combines radiotherapy and chemotherapy is superior to radiotherapy or chemotherapy alone,with the similar effectiveness as surgery;furthmore,concurrent radiotherapy and chemotherapy is superior to the sequential approach.Concurrent radiochemotherapy is suitable for patient with good general conditions and is less than 70 years.Patients with serious medical conditions should not receive concurrent radiochemotherapy.The requirements of radiotherapy methods in concurrent radiochemotherapy include the correct position and CTV delineation.Prophylactic lymph node irradiation is unnecessary. The chemotherapy regimens of concurrent radiochemotherapy includes CE,TP,DP,and GP.The total cycles of chemotherapy should be no more than four cycles.The pre-induction chemotherapy before concurrent radiochemotherapy is unnecessary and the consolidation chemotherapy after concurrent radiochemotherapy remains controversial.The varieties of platinum-based chemotherapy regimens have showed similar efficacies.The weekly schemes have similar efficacies and toxicities with the daily schemes.Pemetrexed combined with carboplatin is a new alternative scheme.Concurrent radiochemotherapy initialed at the beginning of the treatment is better than to be performed after induction chemotherapy.Concurrent radiochemotherapy combined with molecular targeted drugs is a new therapeutical direction.

Standardization of concurrent radiochemotherapy in locally advanced NSCLC